Trial Profile
The Influence of Anti-Müllerian Hormone on Ovarian Responsiveness to Ovulation Induction With Gonadotrophins in Women With Polycystic Ovarian Syndrome
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Menotropin (Primary)
- Indications Polycystic ovary syndrome
- Focus Therapeutic Use
- 05 Feb 2018 New trial record